Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2017 2
2018 2
2019 8
2020 18
2021 14
2022 14
2023 14
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Systemic mastocytosis: 2023 update on diagnosis and management in adults.
Costa A, Scalzulli E, Carmosino I, Capriata M, Ielo C, Masucci C, Passucci M, Martelli M, Breccia M. Costa A, et al. Among authors: scalzulli e. Expert Opin Emerg Drugs. 2023 Dec;28(3):153-165. doi: 10.1080/14728214.2023.2221028. Epub 2023 Jun 6. Expert Opin Emerg Drugs. 2023. PMID: 37256917 Review.
Solitary Plasmacytoma.
Grammatico S, Scalzulli E, Petrucci MT. Grammatico S, et al. Among authors: scalzulli e. Mediterr J Hematol Infect Dis. 2017 Aug 23;9(1):e2017052. doi: 10.4084/MJHID.2017.052. eCollection 2017. Mediterr J Hematol Infect Dis. 2017. PMID: 28894561 Free PMC article. Review.
Asciminib in chronic myeloid leukemia.
Assanto GM, Scalzulli E, Breccia M. Assanto GM, et al. Among authors: scalzulli e. Drugs Today (Barc). 2022 Oct;58(10):479-489. doi: 10.1358/dot.2022.58.10.3441853. Drugs Today (Barc). 2022. PMID: 36305542 Review.
Proteasome inhibitors for the treatment of multiple myeloma.
Scalzulli E, Grammatico S, Vozella F, Petrucci MT. Scalzulli E, et al. Expert Opin Pharmacother. 2018 Mar;19(4):375-386. doi: 10.1080/14656566.2018.1441287. Epub 2018 Feb 26. Expert Opin Pharmacother. 2018. PMID: 29478351 Review.
Measuring prognosis in chronic myeloid leukemia: what's new?
Breccia M, Efficace F, Scalzulli E, Ciotti G, Maestrini G, Colafigli G, Martelli M. Breccia M, et al. Among authors: scalzulli e. Expert Rev Hematol. 2021 Jun;14(6):577-585. doi: 10.1080/17474086.2021.1938534. Epub 2021 Jun 14. Expert Rev Hematol. 2021. PMID: 34075852 Review.
The advantages and risks of ruxolitinib for the treatment of polycythemia vera.
Colafigli G, Scalzulli E, Pepe S, Di Prima A, Efficace F, Martelli M, Foà R, Breccia M. Colafigli G, et al. Among authors: scalzulli e. Expert Rev Hematol. 2020 Oct;13(10):1067-1072. doi: 10.1080/17474086.2020.1816819. Epub 2020 Sep 11. Expert Rev Hematol. 2020. PMID: 32873088 Review.
Asciminib as a third line option in chronic myeloid leukemia.
Laganà A, Scalzulli E, Carmosino I, Martelli M, Breccia M. Laganà A, et al. Among authors: scalzulli e. Int J Hematol. 2023 Jan;117(1):16-23. doi: 10.1007/s12185-022-03432-7. Epub 2022 Aug 5. Int J Hematol. 2023. PMID: 35930119 Review.
68 results